Close readings
The HESIVAXs topic reads as a live observatory of vaccine doubt, where behavioural science, public-health messaging and platform dynamics sit side by side. Gilbert C FAURE does not simply collect vaccine news; he tracks the information environment around hesitation, including research on how misinformation persuades and how counter-messaging might work.
Study finds that to counter misinformation online, we need to copy its style | Thorsten Koch, MA, PgDip
The feed keeps the clinical stakes visible. Measles outbreaks, mumps risk, influenza vaccination drivers and respiratory protection appear not as isolated alerts, but as evidence that trust, policy and disease control are tightly linked.
Surging Measles Outbreaks May Fuel Mumps And Other Infections | Judy Stone
A strong legal and political layer gives the topic its sharp edge. U.S. vaccine battles, Texas investigations, election-season framing and French material on fake news place vaccination inside a larger struggle over institutions, regulation and public confidence.
Texas Pediatricians Face Paxton Vaccine Incentive Probe | George Niles Mekeel
In Immunology and Biotherapies, the center of gravity is translational. The topic moves from immune pathways to drugs, from mechanisms to clinical development, with immunopharmacology, checkpoints, T-cell engagers, CAR-T and cancer vaccines forming a practical map of where the field is moving.
Drugging the immune system: principles of immunopharmacology | Nature Reviews Immunology
Vaccines remain a structural thread rather than a side interest. Systems vaccinology, mucosal strategies, mRNA platforms, HIV work and cancer vaccines show a long view of immunity as both a biological architecture and a therapeutic toolbox.
Systems vaccinology and the architecture of human immunity - Nature | Sam Li
The voice is restrained, but the selection is ambitious. Academic reviews, clinical updates and biotech signals are placed together, suggesting a teacher’s resource for readers who need to understand not only what is new, but why it matters for practice.
Pancreatic cancer peptide vaccine shows promise in patients | Dorit Reiss
The personal notebook is the most revealing of the non-clinical topics. It shows a long-running concern with how knowledge is produced, reviewed, distorted and taught, especially under pressure from AI, research metrics and publication fraud.
Un cancer au cœur de la recherche contre le cancer : la menace grandissante des fabriques à articles scientifiques | Stéphane SAUVAGERE
AI appears here less as novelty than as a stress test for scholarship. Posts about LLMs, academic writing and research workflows sit beside reminders that tools can accelerate work while also weakening judgment if readers stop asking where evidence comes from.
Is up to 80% of the content of the research literature already available in an LLM? In 1950 Norbert Wiener worried less about machines doing the work of people than about people becoming component...
The recurring attention to peer review, paper mills, retractions and Publish or Perish gives the topic a moral spine. It is a scrapbook, but one with a clear anxiety: scientific authority depends on habits, systems and safeguards that need constant maintenance.
The story of Publish or Perish | Anne-Wil Harzing 🟪